Key Takeaways:
- Locus Fermentation Solutions has retained Hilco Global IP Services to seek buyers for more than 120 non-core patents and patent applications covering five technology areas.
- The patent portfolio spans animal nutrition, cement, health and pharma, food production, and textile printing and dyeing, with coverage across multiple global jurisdictions.
- The assets are available for acquisition in full or in part, with interested parties required to sign a non-disclosure agreement with Hilco Global before receiving further information.
- Locus Fermentation Solutions has shifted its strategic focus toward commercialisation of its core biosurfactant and fermentation technologies.
- The portfolio covers innovations developed over more than a decade of R&D investment, including technologies targeting greenhouse gas reduction, drug bioavailability, and industrial water usage.
Locus Fermentation Solutions Makes Non-Core Patent Portfolio Available for Purchase
Locus Fermentation Solutions, a biotech company based in Solon, Ohio, has engaged Hilco Global IP Services to manage the sale of more than 120 patents and patent applications that the company considers non-core to its current business direction. The portfolio is available for acquisition in its entirety or as individual segments by industry.
Locus Fermentation Solutions was founded over a decade ago with a focus on fermentation-enabled molecules and biosurfactants. In recent years, the company has narrowed its commercial focus and identified several technology areas it no longer intends to pursue directly.
What the Locus Fermentation Portfolio Covers
Animal Nutrition
The largest segment of the portfolio available from Locus Fermentation Solutions comprises more than 60 patents and applications across 14 jurisdictions in Asia, Europe, and North and South America. The technologies centre on the use of microbial compositions to improve animal health, feed efficiency, and environmental outcomes in agriculture and aquaculture.
Independent studies conducted by four universities examined the effectiveness of Locus Fermentation Solutions’ feed additives on reducing enteric methane emissions. Preliminary in vitro results showed up to 25% methane mitigation using a Bacillus subtilis preparation, while a direct-fed microbial product called Amplio demonstrated up to 78% methane reductions in in vitro testing.
Cement
Locus Fermentation Solutions holds 8 patents and applications across the U.S., Brazil, China, India, Japan, Mexico, and Vietnam covering biosurfactant additives for use in cement and concrete formulations. The technology is designed to reduce reliance on clinker — a key driver of cement’s carbon footprint — while improving properties such as strength and workability.
Cement is reported to account for 6% to 8% of global annual greenhouse gas emissions. Third-party trials of Locus Fermentation Solutions’ biosurfactant additives at dosage rates as low as 0.1% showed improved hydration and increased strength compared to traditional chemistries.
Health and Pharma
The health and pharma segment covers more than 40 patents and applications across 15 jurisdictions in Africa, Asia, Australia, Europe, and North and South America. The technologies relate to the use of biosurfactants as functional excipients — additives that can disrupt biofilms, improve drug solubility and bioavailability, and support alternative delivery routes for medicines and supplements.
Food Production
Locus Fermentation Solutions holds more than six patents with coverage in Canada, Costa Rica, India, Mexico, and Malaysia in the food sector. The patents cover two technology areas: biosurfactants and microbial compositions for use as emulsifiers and stabilisers in food products, and methods for remediating food processing waste including fats, oils, and grease that accumulate in industrial processing systems.
Textiles
The textiles segment comprises seven patents across the U.S., Australia, China, India, and Vietnam. The covered technologies apply biosurfactant additives to textile production, leather tanning, and paper and fabric printing and dyeing processes, with the stated aims of reducing water and chemical usage and lowering wastewater pollution.
How the Acquisition Process Works
Hilco Global IP Services is accepting non-binding indications of interest for the full portfolio or any selection of patents within it. Locus Fermentation Solutions may negotiate with interested parties at any time and enter into a transaction if an indication of interest is deemed acceptable.
Interested parties are required to contact Hilco Global to obtain a non-disclosure agreement before accessing additional information about the portfolio.
Background on Locus Fermentation Solutions
Locus Fermentation Solutions’ core platform is built around the identification and control of microbial strains used to produce biosurfactants, including sophorolipids and glycolipid-enhanced intermediates. The company’s stated commercial focus covers applications in industries such as oil extraction, agriculture, and specialty cleaning, where it supplies bio-based alternatives to conventional chemicals.
The company describes the patent sale as an opportunity for operators in the relevant sectors to acquire assets representing years of R&D investment without the associated development costs.
